Bids Are Invited For Terumo - Abdominal & Thoracic Stent Graft System in Canada

Work Detail

Notice Of Intent To Direct Awardissued: January 23, 2026File # Phsa 18258Noi Title: Terumo - Abdominal & Thoracic Stent Graft Systemprovincial Health Services Authoritynotice Is Hereby Given That, Fraser Health Authority, Interior Health Authority, Vancouver Coastal Health Authority And Vancouver Island Health Authority (The “Health Authority(S)”), Through Their Collective Agent Provincial Health Services Authority (“Phsa”), Intends To Directly Award A Contract To The Following Supplier To Provide Consumables For Evar (Endovascular Aneurysm Repair) And Tevar (Thoracic Endovascular Aortic Repair) For Fraser Health Authority, Interior Health Authority, Vancouver Coastal Health Authority And Vancouver Island Health Authority For A Term Of Three (3) Years And Two (2) Months At An Estimated Value Of $4.65 Million.Terumo Medical Canada Inc.10911 Keele St., Units 2-4 Vaughan, Ontario L6a 5A6 In Accordance With Applicable Trade Agreements, Phsa, As Agent For The Health Authority(S), Has Chosen Not To Proceed With A Competitive Process For The Following Reason:The Goods Or Services Can Be Supplied Only By The Selected Supplier And No Alternative Or Substitute Exists For The Following Reason;Due To An Absence Of Competition For Technical Reasons.These Consumables Are Used In Evar And Tevar Procedures, Which Are Minimally Invasive Techniques Involving The Placement Of A Stent Graft To Treat Aortic Aneurysms. An Interventional Radiologist Places A Covered Stent (A Metal Mesh Tube Covered With Fabric) Into The Affected Area Of The Artery To Reinforce The Weakened Or Bulging Section Of The Main Artery.Among The Existing Technologies, The Terumo Aortic Treo Abdominal Stent Graft System Offers Flexible Graft Design, Dual Active Fixation, Optimized Proximal Seal, And Lock Stent Technology. The Delivery System Offers Low Profile Delivery System, Controlled, Precise Graft Delivery, Leave Behind Sheath And A Protective Proximal Clasp.Vendors Who Wish To Challenge This Decision Should Submit A Detailed Written Objection For The Attention Of Jasjit Gill, Buyer – Cardiac & Perioperative Interventions, By Email To Jasjit.Gill@Phsa.Ca Before 12:00 P.M Pacific Time, February 2, 2026. Phsa Will Review Any And All Issues Received By This Date And Provide Due Consideration To Each Objection.

Contact Information